Javed, M., Kigozi, J., Moakes, C. A., Bate, G. R., Hall, J. A., Deeks, J. J., . . . Mezes, P. (2026). Plain balloon angioplasty with or without bare-metal stenting versus drug-coated balloon angioplasty with or without bare-metal stenting versus primary drug-eluting stenting in patients requiring femoropopliteal, with or without infrapopliteal, endovascular revascularization for chronic limb-threatening ischaemia: BASIL-3 within-trial health economic analysis. British Journal of Surgery, 113(3), 1. https://doi.org/10.1093/bjs/znaf274
Chicago Style (17th ed.) CitationJaved, Mishal, et al. "Plain Balloon Angioplasty with or Without Bare-metal Stenting Versus Drug-coated Balloon Angioplasty with or Without Bare-metal Stenting Versus Primary Drug-eluting Stenting in Patients Requiring Femoropopliteal, with or Without Infrapopliteal, Endovascular Revascularization for Chronic Limb-threatening Ischaemia: BASIL-3 Within-trial Health Economic Analysis." British Journal of Surgery 113, no. 3 (2026): 1. https://doi.org/10.1093/bjs/znaf274.
MLA (9th ed.) CitationJaved, Mishal, et al. "Plain Balloon Angioplasty with or Without Bare-metal Stenting Versus Drug-coated Balloon Angioplasty with or Without Bare-metal Stenting Versus Primary Drug-eluting Stenting in Patients Requiring Femoropopliteal, with or Without Infrapopliteal, Endovascular Revascularization for Chronic Limb-threatening Ischaemia: BASIL-3 Within-trial Health Economic Analysis." British Journal of Surgery, vol. 113, no. 3, 2026, p. 1, https://doi.org/10.1093/bjs/znaf274.